<?xml version="1.0" encoding="utf-8"?>
<!-- Copyright Â©2016 LexisNexis Univentio, The Netherlands. -->
<lexisnexis-patent-document schema-version="1.13" date-produced="20160127" file="US20150257400A1.xml" produced-by="LexisNexis-Univentio" lang="eng" date-inserted="20150917" time-inserted="030218" date-changed="20151223" time-changed="182846">
  <bibliographic-data lang="eng">
    <publication-reference publ-type="Application" publ-desc="Patent Application Publication">
      <document-id id="121315949">
        <country>US</country>
        <doc-number>20150257400</doc-number>
        <kind>A1</kind>
        <date>20150917</date>
      </document-id>
    </publication-reference>
    <application-reference appl-type="utility">
      <document-id>
        <country>US</country>
        <doc-number>14208959</doc-number>
        <date>20140313</date>
      </document-id>
    </application-reference>
    <application-series-code>14</application-series-code>
    <language-of-filing>eng</language-of-filing>
    <language-of-publication>eng</language-of-publication>
    <dates-of-public-availability date-changed="20150924">
      <unexamined-printed-without-grant>
        <date>20150917</date>
      </unexamined-printed-without-grant>
    </dates-of-public-availability>
    <classifications-ipcr date-changed="20151223">
      <classification-ipcr sequence="1">
        <text>A23B   4/22        20060101AFI20150917BHUS        </text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>23</class>
        <subclass>B</subclass>
        <main-group>4</main-group>
        <subgroup>22</subgroup>
        <symbol-position>F</symbol-position>
        <classification-value>I</classification-value>
        <action-date>
          <date>20150917</date>
        </action-date>
        <generating-office>
          <country>US</country>
        </generating-office>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
      </classification-ipcr>
      <classification-ipcr sequence="2">
        <text>A61K  35/74        20150101ALI20150917BHUS        </text>
        <ipc-version-indicator>
          <date>20150101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>35</main-group>
        <subgroup>74</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <action-date>
          <date>20150917</date>
        </action-date>
        <generating-office>
          <country>US</country>
        </generating-office>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
      </classification-ipcr>
    </classifications-ipcr>
    <classifications-cpc date-changed="20151223">
      <classification-cpc sequence="1">
        <text>A23B   4/22        20130101 FI20150917BHEP        </text>
        <cpc-version-indicator>
          <date>20130101</date>
        </cpc-version-indicator>
        <section>A</section>
        <class>23</class>
        <subclass>B</subclass>
        <main-group>4</main-group>
        <subgroup>22</subgroup>
        <symbol-position>F</symbol-position>
        <classification-value>I</classification-value>
        <action-date>
          <date>20150917</date>
        </action-date>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
      </classification-cpc>
      <classification-cpc sequence="2">
        <text>A61K  35/742       20130101 LI20151210BHEP        </text>
        <cpc-version-indicator>
          <date>20130101</date>
        </cpc-version-indicator>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>35</main-group>
        <subgroup>742</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <action-date>
          <date>20151210</date>
        </action-date>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
      </classification-cpc>
    </classifications-cpc>
    <number-of-claims calculated="yes">19</number-of-claims>
    <invention-title id="title_eng" date-changed="20150917" lang="eng" format="original">STRAINS OF BACILLUS FOR INHIBITING FOODBORNE PATHOGENS</invention-title>
    <references-cited date-changed="20150929">
      <patent-citations name="patcit" date-changed="20150929" />
      <citation>
        <patcit num="1" dnum="US6498137B1" dnum-type="publication number">
          <document-id>
            <country>US</country>
            <doc-number>6498137</doc-number>
            <kind>B1</kind>
            <name>SCHALITZ WILLIAM J [US], et al</name>
            <date>20021224</date>
          </document-id>
          <application-date>
            <date>20020319</date>
          </application-date>
        </patcit>
      </citation>
    </references-cited>
    <parties date-changed="20150917">
      <applicants>
        <applicant sequence="1" app-type="applicant">
          <addressbook lang="eng">
            <orgname>Osprey Biotechnics, Inc.</orgname>
            <role>02</role>
            <address>
              <city>Sarasota</city>
              <state>FL</state>
              <country>US</country>
            </address>
          </addressbook>
        </applicant>
      </applicants>
      <inventors>
        <inventor sequence="1" designation="us-only">
          <addressbook lang="eng">
            <last-name>Reuter</last-name>
            <first-name>Christopher J.</first-name>
            <address>
              <city>Parrish</city>
              <state>FL</state>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="2" designation="us-only">
          <addressbook lang="eng">
            <last-name>MacKenzie</last-name>
            <first-name>Steven J.</first-name>
            <address>
              <city>Sarasota</city>
              <state>FL</state>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="3" designation="us-only">
          <addressbook lang="eng">
            <last-name>Danielson</last-name>
            <first-name>Lauren G.</first-name>
            <address>
              <city>Bradenton</city>
              <state>FL</state>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
        <inventor sequence="4" designation="us-only">
          <addressbook lang="eng">
            <last-name>Scuilla</last-name>
            <first-name>Vincent</first-name>
            <address>
              <city>Sarasota</city>
              <state>FL</state>
              <country>US</country>
            </address>
          </addressbook>
        </inventor>
      </inventors>
    </parties>
    <patent-family date-changed="20151015">
      <main-family family-id="173669659">
        <family-member>
          <document-id>
            <country>WO</country>
            <doc-number>2015138539</doc-number>
            <kind>A1</kind>
            <date>20150917</date>
          </document-id>
          <application-date>
            <date>20150311</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>WO</country>
            <doc-number>2015138539</doc-number>
            <kind>A4</kind>
            <date>20151015</date>
          </document-id>
          <application-date>
            <date>20150311</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>US</country>
            <doc-number>20150257400</doc-number>
            <kind>A1</kind>
            <date>20150917</date>
          </document-id>
          <application-date>
            <date>20140313</date>
          </application-date>
        </family-member>
      </main-family>
      <complete-family family-id="173669650">
        <family-member>
          <document-id>
            <country>WO</country>
            <doc-number>2015138539</doc-number>
            <kind>A1</kind>
            <date>20150917</date>
          </document-id>
          <application-date>
            <date>20150311</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>WO</country>
            <doc-number>2015138539</doc-number>
            <kind>A4</kind>
            <date>20151015</date>
          </document-id>
          <application-date>
            <date>20150311</date>
          </application-date>
        </family-member>
        <family-member>
          <document-id>
            <country>US</country>
            <doc-number>20150257400</doc-number>
            <kind>A1</kind>
            <date>20150917</date>
          </document-id>
          <application-date>
            <date>20140313</date>
          </application-date>
        </family-member>
      </complete-family>
    </patent-family>
  </bibliographic-data>
  <abstract id="abstr_eng" date-changed="20150917" lang="eng" format="original">
    <p id="p-a-00001-en" num="0000">A process for inhibiting foodborne pathogens and reducing foodborne disease involves contacting a living animal, a dressed carcass, or a cut of meat with an effective amount of a bacillus strain exhibiting antibacterial activity. Strains of antibacterial bacillus that are particularly effective for inhibiting Vibrio were discovered. These include <i>Bacillus licheniformis </i>OBT 712 and <i>Bacillus amyloliquefaciens </i>OBT 618.</p>
  </abstract>
  <legal-data date-changed="20151002">
    <legal-event sequence="1">
      <publication-date>
        <date>20140318</date>
      </publication-date>
      <event-code-1>AS</event-code-1>
      <legal-description>ASSIGNMENT</legal-description>
      <status-identifier>N</status-identifier>
      <docdb-publication-number> US  2015257400A1</docdb-publication-number>
      <docdb-application-id>444510492</docdb-application-id>
      <new-owner>OSPREY BIOTECHNICS, INC., FLORIDA</new-owner>
      <free-text-description>ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:REUTER, CHRISTOPHER J;MACKENZIE, STEVEN J;DANIELSON, LAUREN G;AND OTHERS;SIGNING DATES FROM 20140304 TO 20140305;REEL/FRAME:032459/0265</free-text-description>
    </legal-event>
    <legal-event sequence="2">
      <publication-date>
        <date>20140318</date>
      </publication-date>
      <event-code-1>AS</event-code-1>
      <legal-description>ASSIGNMENT</legal-description>
      <status-identifier>N</status-identifier>
      <docdb-publication-number> US  2015257400A1</docdb-publication-number>
      <docdb-application-id>444510492</docdb-application-id>
      <new-owner>OSPREY BIOTECHNICS, INC., FLORIDA</new-owner>
      <free-text-description>ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:REUTER, CHRISTOPHER J.;MACKENZIE, STEVEN J.;DANIELSON, LAUREN G.;AND OTHERS;SIGNING DATES FROM 20140304 TO 20140305;REEL/FRAME:032459/0355</free-text-description>
    </legal-event>
  </legal-data>
  <description id="descr_eng" lang="eng" format="original" date-changed="20150917">
    <summary>
      <heading id="h-00001-en" level="1">CROSS-REFERENCE TO RELATED APPLICATIONS</heading>
      <p id="p-00001-en" num="0001">Not Applicable.</p>
      <heading id="h-00002-en" level="1">FIELD OF THE DISCLOSURE</heading>
      <p id="p-00002-en" num="0002">This disclosure relates to the use of bacillus strains to inhibit the growth, reproduction or propagation of foodborne pathogens to improve food safety and reduce incidents of disease such as gastroenteritis.</p>
      <heading id="h-00003-en" level="1">BACKGROUND OF THE DISCLOSURE</heading>
      <p id="p-00003-en" num="0003">Foodborne disease caused by contamination from pathogenic bacteria is likely responsible for millions of illnesses annually (at least about 8 million in the United States of America annually according to CDC 2011 estimates), thousands of which result in hospitalization annually, and about 1000 fatalities annually. Foodborne disease generally occurs with at least a similar frequency throughout the world and is the leading cause of illness and death in certain parts of the world.</p>
      <p id="p-00004-en" num="0004">Known antibacterial agents such as alcohols, chlorine, peroxides, aldehydes, triclosan, triclocarban, and benzalkonium chloride are unsuitable for use in foods due to their inherent toxicity. Treatment with gaseous antibacterial agents (such as ozone or ethylene oxide) or irradiation (such as with ionizing radiation or x-rays) can be safe, effective and economically advantageous in certain cases, but are not favorably perceived by the public. Such techniques have also been criticized by public interest groups and public health experts for various reasons, including allegations that these techniques can mask food spoilage, discourage adherence to good food processing practices, kill beneficial bacteria (e.g., probiotics), denature or degrade nutrients, impair flavor and leave bacterial toxins that were present before the treatment.</p>
      <p id="p-00005-en" num="0005">
        <i>Bacillus </i>strains exhibiting antifungal activity and the use of such bacteria to control plant diseases are described in the literature (e.g., U.S. Pat. No. 6,291,426).</p>
      <p id="p-00006-en" num="0006">Antibacterial activity of secondary metabolites obtained from Pseudomonas strains has been reported in the literature (e.g., E. Madhava Charyulu et al., Indian Journal of Experimental Biology, Vol. 47, December 2009, pp. 964-968). It was proposed that such secondary metabolites could be useful in new drugs such as antimicrobial drugs.</p>
      <p id="p-00007-en" num="0007">Accordingly, new and effective methods of reducing foodborne disease are desired.</p>
      <heading id="h-00004-en" level="1">SUMMARY OF THE DISCLOSURE</heading>
      <p id="p-00008-en" num="0008">Disclosed is a method of inhibiting foodborne pathogens and thereby reducing foodborne disease by applying to or feeding to a living animal, an animal carcass or to cuts of meat an effective amount of a bacillus strain exhibiting antibacterial activity.</p>
      <p id="p-00009-en" num="0009">Also disclosed are specific strains of antibacterial bacilli that are particularly effective at inhibiting <i>Vibrio</i>. These include <i>Bacillus licheniformis </i>OBT 712, characterized by the sequence shown in <figref>FIG. 1</figref> and <i>Bacillus amyloliquefaciens </i>OBT 618, characterized by the sequence shown in <figref>FIG. 2</figref>.</p>
    </summary>
    <description-of-drawings>
      <heading id="h-00005-en" level="1">BRIEF DESCRIPTION OF THE DRAWINGS</heading>
      <p id="p-00010-en" num="0010">
        <figref>FIG. 1</figref> (SEQ ID NO: 1) is the relevant sequence for <i>Bacillus licheniformis </i>OBT 712.</p>
      <p id="p-00011-en" num="0011">
        <figref>FIG. 2</figref> (SEQ ID NO: 2) is the relevant sequence listing for <i>Bacillus amyloliquefaciens </i>OBT 618.</p>
      <p id="p-00012-en" num="0012">
        <figref>FIG. 3</figref> is a schematic illustration of the preparation of an antibacterial bacillus strain isolate.</p>
      <p id="p-00013-en" num="0013">
        <figref>FIG. 4</figref> is a schematic illustration of a process for screening isolates that are antagonistic toward an isolate of <i>Vibrio </i>sp. selected from a marine environment using an agar overlay method.</p>
      <p id="p-00014-en" num="0014">
        <figref>FIG. 5</figref> is a photograph showing a comparison of a positive (â+â) result for <i>Bacillus amyloliquefaciens </i>OBT 612 to a negative (âââ) control.</p>
    </description-of-drawings>
    <detailed-desc>
      <heading id="h-00006-en" level="1">DESCRIPTION OF THE DISCLOSED EMBODIMENTS</heading>
      <p id="p-00015-en" num="0015">It has been discovered that foodborne pathogens can be inhibited when contacted with an effective amount of a bacillus strain exhibiting antibacterial activity.</p>
      <p id="p-00016-en" num="0016">The term âinhibitâ means to reduce or arrest growth and/or reproduction of bacterial pathogens that can cause foodborne diseases, and encompasses killing such bacterial pathogens.</p>
      <p id="p-00017-en" num="0017">The term âeffective amountâ means an amount that will achieve a desired level of foodborne pathogen inhibition to effect a beneficial result such as reducing bacterial pathogen populations in or on food, or in or on animals that are processed into foods.</p>
      <p id="p-00018-en" num="0018">Foodborne pathogens that can be inhibited include <i>Salmonella </i>enteric, <i>Escherichia coli, Clostridium difficile </i>and <i>Vibrio. </i></p>
      <p id="p-00019-en" num="0019">
        <i>Bacillus </i>strains exhibiting antibacterial activity include <i>Bacillus licheniformis </i>strains (e.g., OBT 712), and <i>Bacillus amyloliquefaciens </i>strains (e.g., OBT 618). The relevant sequence listings for <i>Bacillus licheniformis </i>OBT 712 and <i>Bacillus amyloliquefaciens </i>OBT 618 are shown in <figref>FIGS. 1 and 2</figref>, respectively.</p>
      <p id="p-00020-en" num="0020">The step of contacting the foodborne pathogens with a bacillus strain exhibiting antibacterial activity can involve application of an aqueous based composition containing the antibacterial bacillus strain to a live animal, a dressed carcass or cuts of meat, such as by spraying, brushing or dipping. In the case of aquatic animals, the antibacterial bacillus strain can be added to a container, tank or enclosure (e.g., a fish hatchery) in which the aquatic animals are raised and/or from which they are harvested. As another alternative, contact between the bacterial pathogens and the antibacterial bacillus can be achieved by feeding the antibacterial bacillus to the animal, either directly or to animals that serve as the food source for the animal that is ultimately processed for consumption such as by a human or companion animal.</p>
      <p id="p-00021-en" num="0021">
        <figref>FIG. 3</figref> shows a method of preparing an antibacterial bacillus strain isolate. Samples from marine environments were selected for spore-forming bacillus and Vibrio species. The bacillus samples were enriched, and subsequently pasteurized at about 70Â° C. <i>Bacillus </i>isolates were then placed on sporulation agar. The Vibrio was placed on thiosulfate-citrate-bile salts-sucrose (TCBS) agar.</p>
      <p id="p-00022-en" num="0022">
        <figref>FIG. 4</figref> shows an assay to determine growth inhibition for the bacillus strains. A candidate bacillus spore-former is placed on a trypticase soy agar (TSA) plate, and thereafter, <i>Vibrio </i>isolate embedded in top agar is disposed over the TSA plate. After a sufficient period (e.g., two days), the zones in which the candidate bacillus strains are overlaid with the <i>Vibrio </i>isolates are inspected for clearance of the <i>Vibrio</i>. Positive results are illustrated on the right side of the agar dish at Step 3 of <figref>FIG. 4</figref>.</p>
      <p id="p-00023-en" num="0023">
        <figref>FIG. 5</figref> is a photograph showing an actual positive result labeled âHB8(+)â and a negative result labeled âControl(â).â</p>
      <p id="p-00024-en" num="0024">Isolates were screened for antagonism toward an isolate of <i>Vibrio </i>sp. selected from a marine environment using an agar overlay method. This method consisted of covering one day old bacillus cultures with the <i>Vibrio </i>isolate embedded in agar. Zones of clearance were evaluated at 2 days. Thirty-six isolates from various environments were screened. Of the thirty-six isolates tested, two isolates, a B. licheniformis (OBT 712) and a <i>B. amyloliquefaciens </i>(OBT 618), had particularly high levels of antagonism toward <i>Vibrio</i>. All strains are easily propagated on trypticase soy agar (TSA) and sporulate in liquid media.</p>
      <p id="p-00025-en" num="0025">These strains are antagonistic to <i>Vibrio</i>. They produce a clearance zone on agar plates when the <i>Bacillus </i>colonies are covered with a thin agar layer that includes <i>Vibrio </i>sp. One isolate has a delayed response killing the <i>Vibrio </i>after it has grown. The other inhibits <i>Vibrio </i>growth.</p>
      <p id="p-00026-en" num="0026">In a preliminary trial, feeding rotifers the <i>Bacillus </i>strains increased survivability of larval snook fed the rotifers. The mechanism by which the <i>Bacillus </i>isolates fed to rotifers increases survivability of larval snook fed the rotifers has not been determined. It is conceivable that they are inhibiting growth of <i>Vibrio </i>within the digestive tract of rotifers or snook. It is also possible that they inhibit growth of <i>Vibrio </i>within larval brooding tanks overall.</p>
      <p id="p-00027-en" num="0027">Anticipated use is at a concentration of 10<sup>5</sup>-10<sup>7 </sup>spores/ml in live food tanks or in a larval rearing tank. They are stored as freeze dried spores. Spores can be supplied on a nutritive carrier.</p>
      <p id="p-00028-en" num="0028">The invention could possibly be used to suppress <i>Vibrio </i>sp. on multiple fish species as well as shell fish that are grown in culture. <i>Vibrio </i>is a gammaproteobacteria, a class of bacteria that includes Pseudomonas and Enterobacter such as <i>E. coli </i>and <i>Salmonella </i>sp. It could potentially be antagonistic to these other species.</p>
      <p id="p-00029-en" num="0029">Possible ancillary benefits of <i>Bacillus </i>addition in aquaculture include improved nutrient availability and waste reduction.</p>
      <p id="p-00030-en" num="0030">The described embodiments are preferred and/or illustrated, but are not limiting. Various modifications are considered within the purview and scope of the appended claims.</p>
    </detailed-desc>
  </description>
  <us-claim-statement>What is claimed is:</us-claim-statement>
  <claims id="claims_eng" lang="eng" format="original" date-changed="20150917">
    <claim num="1" id="clm-00001-en" independent="true">
      <claim-text>
        <b>1</b>. A process for inhibiting foodborne pathogens, comprising contacting a living animal, dressed carcass, or cut of meat with an effective amount of a bacillus strain exhibiting antibacterial activity.</claim-text>
    </claim>
    <claim num="2" id="clm-00002-en">
      <claim-text>
        <b>2</b>. The process of <claim-ref idref="clm-00001-en">claim 1</claim-ref>, in which the foodborne pathogen is known to be present in or on the living animal, dressed carcass, or cut of meat.</claim-text>
    </claim>
    <claim num="3" id="clm-00003-en">
      <claim-text>
        <b>3</b>. The process of <claim-ref idref="clm-00002-en">claim 2</claim-ref>, in which the foodborne pathogen is at least one of Salmonella enteric, Escherichia coli or Clostridium difficile. </claim-text>
    </claim>
    <claim num="4" id="clm-00004-en">
      <claim-text>
        <b>4</b>. The process of <claim-ref idref="clm-00002-en">claim 2</claim-ref>, in which the foodborne pathogen is Vibrio. </claim-text>
    </claim>
    <claim num="5" id="clm-00005-en">
      <claim-text>
        <b>5</b>. The process of <claim-ref idref="clm-00001-en">claim 1</claim-ref>, in which the antibacterial bacillus is a Bacillus licheniformis. </claim-text>
    </claim>
    <claim num="6" id="clm-00006-en">
      <claim-text>
        <b>6</b>. The process of <claim-ref idref="clm-00001-en">claim 1</claim-ref>, in which the antibacterial bacillus is a Bacillus amyloliquefacien. </claim-text>
    </claim>
    <claim num="7" id="clm-00007-en">
      <claim-text>
        <b>7</b>. The process of <claim-ref idref="clm-00001-en">claim 1</claim-ref>, in which the antibacterial bacillus is Bacillus licheniformis OBT 712.</claim-text>
    </claim>
    <claim num="8" id="clm-00008-en">
      <claim-text>
        <b>8</b>. The process of <claim-ref idref="clm-00001-en">claim 1</claim-ref>, in which the antibacterial bacillus is Bacillus amyloliquefaciens OBT 618.</claim-text>
    </claim>
    <claim num="9" id="clm-00009-en">
      <claim-text>
        <b>9</b>. The process of <claim-ref idref="clm-00001-en">claim 1</claim-ref>, in which contacting the living animal, dressed carcass, or cut of meat with the bacillus strain is done by applying an aqueous based composition containing the bacillus strain to the live animal, dressed carcass, or cut of meat.</claim-text>
    </claim>
    <claim num="10" id="clm-00010-en">
      <claim-text>
        <b>10</b>. The process of <claim-ref idref="clm-00009-en">claim 9</claim-ref>, in which the applying is done by spraying, brushing or dipping.</claim-text>
    </claim>
    <claim num="11" id="clm-00011-en">
      <claim-text>
        <b>11</b>. The process of <claim-ref idref="clm-00001-en">claim 1</claim-ref>, in which the process is performed on a living animal, and the contacting is done by feeding the antibacterial bacillus to the living animal.</claim-text>
    </claim>
    <claim num="12" id="clm-00012-en">
      <claim-text>
        <b>12</b>. The process of <claim-ref idref="clm-00001-en">claim 1</claim-ref>, in which the process is performed on a living animal, and the contacting is done by feeding the antibacterial bacillus to an animal that is fed to the living animal on which the process is performed.</claim-text>
    </claim>
    <claim num="13" id="clm-00013-en">
      <claim-text>
        <b>13</b>. The process of <claim-ref idref="clm-00012-en">claim 12</claim-ref>, in which the living animal is an aquatic animal and the animal that is fed to the living animal on which the process is performed is a rotifer.</claim-text>
    </claim>
    <claim num="14" id="clm-00014-en">
      <claim-text>
        <b>14</b>. The process of <claim-ref idref="clm-00001-en">claim 1</claim-ref>, in which the process is performed on a living animal, wherein the living animal is a fish or a shell fish contained in tank holding water, and wherein the antibacterial bacillus is added to the water in the tank in the form of spores.</claim-text>
    </claim>
    <claim num="15" id="clm-00015-en">
      <claim-text>
        <b>15</b>. The process of <claim-ref idref="clm-00014-en">claim 14</claim-ref>, in which the concentration of antibacterial bacillus spores in the water is from 10<sup>5 </sup>to 10<sup>7 </sup>spores/ml.</claim-text>
    </claim>
    <claim num="16" id="clm-00016-en" independent="true">
      <claim-text>
        <b>16</b>. A <i>Bacillus </i>isolate exhibiting antibacterial activity.</claim-text>
    </claim>
    <claim num="17" id="clm-00017-en" independent="true">
      <claim-text>
        <b>17</b>. <i>Bacillus licheniformis </i>OBT 712 as characterized by the sequence in <figref>FIG. 1</figref>.</claim-text>
    </claim>
    <claim num="18" id="clm-00018-en" independent="true">
      <claim-text>
        <b>18</b>. <i>Bacillus amyloliquefaciens </i>OBT 618 as characterized by the sequence in <figref>FIG. 2</figref>.</claim-text>
    </claim>
    <claim num="19" id="clm-00019-en" independent="true">
      <claim-text>
        <b>19</b>. A device for inhibiting foodborne pathogens, comprising:
<claim-text>spores of a bacillus strain exhibiting antibacterial activity; and</claim-text><claim-text>a nutritive carrier supporting the spores.</claim-text></claim-text>
    </claim>
  </claims>
  <drawings id="drawings">
    <figure num="1">
      <img he="N/A" wi="N/A" file="US20150257400A1_00001.PNG" alt="drawing sheet" img-content="drawing" img-format="png" original="US20150257400A1-20150917-D00001.TIF" />
    </figure>
    <figure num="2">
      <img he="N/A" wi="N/A" file="US20150257400A1_00002.PNG" alt="drawing sheet" img-content="drawing" img-format="png" original="US20150257400A1-20150917-D00002.TIF" />
    </figure>
    <figure num="3">
      <img he="N/A" wi="N/A" file="US20150257400A1_00003.PNG" alt="drawing sheet" img-content="drawing" img-format="png" original="US20150257400A1-20150917-D00003.TIF" />
    </figure>
    <figure num="4">
      <img he="N/A" wi="N/A" file="US20150257400A1_00004.PNG" alt="drawing sheet" img-content="drawing" img-format="png" original="US20150257400A1-20150917-D00004.TIF" />
    </figure>
    <figure num="5">
      <img he="N/A" wi="N/A" file="US20150257400A1_00005.PNG" alt="drawing sheet" img-content="drawing" img-format="png" original="US20150257400A1-20150917-D00005.TIF" />
    </figure>
  </drawings>
  <image file="US20150257400A1.PDF" type="pdf" size="582393" pages="9" />
</lexisnexis-patent-document>